- Asian equities dribble as vaccine, stimulus optimism fades during a quiet day.
- RBA’s Kent, Japan Trade numbers fail to entertain markets.
- US President Biden, UK covid task force unveils jab planning, flaunts resources.
- Japan to extend virus-led emergency, Australia also releases covid-related good news.
Shares in Asia-Pacific fizzle the latest uptrend as bulls get tired of the same old while China is still on the New Year holidays during early Wednesday. In doing so, market players ignore US President Joe Biden’s vaccine and stimulus optimism as well as welcome coronavirus (COVID-19) updates from the Pacific majors like Australia and New Zealand.
To portray the mood, MSCI’s index of Asia-Pacific shares outside Japan print 0.20% intraday gains while staying near the record top marked the previous day. On the other hand, Japan’s Nikkei 225 drops 0.50% as virus-led emergency gets another extension from Tokyo. In doing so, the Japanese investors ignore upbeat trade numbers and Machinery Orders for January and December respectively.
Elsewhere, Australia’s Victoria and New Zealand’s Auckland near the end of snap lockdowns as the governments prepare for vaccinations. While the move favors New Zealand’s NZX 50, Australia’s ASX 200 remains mildly offered despite the latest recovery moves.
On the same line, the UK’s immunization task force has conveyed the August-September timeline as the final by which all adults will have two jabs. Further, US President Joe Biden said to have the vaccines for all Americans by July while also teasing upcoming stimulus and the warning to China. Amid these plays, US 10-year Treasury yields ease from the one-year top while the S&P 500 Futures struggle for a clear direction near the record top registered Tuesday.
It’s worth mentioning that the shares in Hong Kong stay mildly bid but those from Indonesia, South Korea and India couldn’t ignore the US dollar’s recovery moves.
Looking forward, investors will keep their eyes on the US Retail Sales for January ahead of FOMC minutes for fresh impulse. Also important will be the updates over the US covid relief package and further easing for activity restrictions from Asia-Pacific.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD struggles to recover above 1.1000 ahead of Fedspeak
EUR/USD holds ground on upbeat German Industrial Production data on Tuesday but finds it difficult to clear the 1.1000 hurdle. In the absence of high-tier macroeconomic data releases from the US, investors will pay close attention to comments from central bankers.
GBP/USD holds steady near 1.3100 as mood sours
GBP/USD trades in a tight channel at around 1.3100 following Monday's decline. The negative shift seen in risk mood doesn't allow the pair to gather recovery momentum as investors await comments from Federal Reserve policymakers.
Gold recovers from weekly lows, trades near $2,650
After falling to a fresh weekly low below $2,630 earlier in the day, Gold gains traction and recovers to the $2,650 area. The precious metal benefits from the negative shift seen in risk mood as geopolitical tensions remain high.
Ripple price shows signs of weakness
Ripple price stabilizes around $0.530 and trades within a tight range for the fourth day in a row on Tuesday. After breaking below its ascending trendline last week, XRP’s price was rejected from its daily resistance level on Monday.
RBA widely expected to keep key interest rate unchanged amid persisting price pressures
The Reserve Bank of Australia is likely to continue bucking the trend adopted by major central banks of the dovish policy pivot, opting to maintain the policy for the seventh consecutive meeting on Tuesday.
Five best Forex brokers in 2024
VERIFIED Choosing the best Forex broker in 2024 requires careful consideration of certain essential factors. With the wide array of options available, it is crucial to find a broker that aligns with your trading style, experience level, and financial goals.